¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"neomycin/ polymyxin B/ prednisolone ophthalmic"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polymyxin
    Æú¸®¹Í½Å
  • prednisolone
    ÇÁ·¹µå´Ï¼Ö·Ð
  • ophthalmic
    ´«-, ¾È±¸-
  • ophthalmic artery
    ´«µ¿¸Æ, ¾Èµ¿¸Æ
  • ophthalmic nerve
    ´«½Å°æ, ¾È½Å°æ
  • ophthalmic neuralgia
    ´«ºÎÀ§½Å°æÅë, ¾È±¸½Å°æÅë
  • ophthalmic remedy
    ¾È°ú¿ë¾àÁ¦
  • ophthalmic solution
    ¾È°ú¿ë¾×
  • ophthalmic vesicle
    ´«¼ÒÆ÷, ¾ÈÆ÷
  • ophthalmic zoster
    ´«¶ìÇ츣Æä½º, ´«´ë»óÆ÷Áø
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ophthalmic
    ´«-
  • prednisolone
    ÇÁ·¹µå´Ï¼Ö·Ð
  • methyl prednisolone
    ¸ÞÆ¿ÇÁ·¹µå´Ï¼Ö·Ð
  • ophthalmic zoster
    ´«¶ìÇ츣Æä½º, ´«´ë»óÆ÷Áø
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polymyxin
    Æú¸®¹Í½Å
  • prednisolone
    ÇÁ·¹µå´Ï¼Ö·Ð
  • ophthalmic artery
    ´«µ¿¸Æ
  • ophthalmic nerve
    ´«½Å°æ
  • ophthalmic neuralgia
    ´«ºÎÀ§½Å°æÅë
  • ophthalmic
    ´«-
  • ophthalmic remedy
    ¾È°ú¿ë¾àÁ¦
  • ophthalmic solution
    ¾È°ú¿ë¾×Á¦
  • ophthalmic vesicle
    (¢¡optic vesicle) ´«¼ÒÆ÷
  • ophthalmic zoster
    ´«¶ìÇ츣Æä½º, ¾ÈºÎ´ë»ó
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inferior ophthalmic vein
    ¾Æ·¡´«Á¤¸Æ
  • polymyxin
    Æú¸®¹Í½Å.
  • prednisolone
    ÇÁ·¹µå´Ï¼Ö·Ð.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polymyxin
    Æú¸®¹Í½Å.
  • methyl prednisolone
    ¸ÞÆ¿ÇÁ·¹µå´Ï¼Ö·Ð.
  • prednisolone
    ÇÁ·¹µå´Ï¼Ö·Ð.
  • inferior ophthalmic vein
    ÇϾÈÁ¤¸Æ, ¾Æ·¡´«Á¤¸Æ
  • inferior ophthalmic vein
    ¾Æ·¡´«Á¤¸Æ
  • ocular vesicle =ophthalmic v., optic v., ³ª vesicula ophthalmica
    ¾ÈÆ÷(äÑøà).
  • ophthalmic artery
    ¾Èµ¿¸Æ(äÑÔÑØæ), ´«µ¿¸Æ
  • ophthalmic artery
    ¾Èµ¿¸Æ, ´«µ¿¸Æ
  • ophthalmic artery
    ´«µ¿¸Æ
  • ophthalmic artery ³ª arteria ophthalmica
    ¾Èµ¿¸Æ(äÑÔÑØæ).
  • ophthalmic assistant
    ¾È°úÁ¶¼ö
  • ophthalmic dispenser
    ¾È°æ»ç
  • ophthalmic migraine
    ¾È¼ºÆíµÎÅë(äÑàõø¶Ôé÷Ô).
  • ophthalmic nerve
    ´«½Å°æ, ¾È½Å°æ(äÑãêÌè).
  • ophthalmic neuralgia
    ¾ÈºÎ½Å°æÅë(äÑÝ»ãêÌè÷Ô).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Ophthalmic artery
    ´«µ¿¸Æ
    [¿¾ ¿ë¾î] ¾Èµ¿¸Æ
  • Inferior ophthalmic vein
    ¾Æ·¡´«Á¤¸Æ
    [¿¾ ¿ë¾î] ÇϾÈÁ¤¸Æ
  • Superior ophthalmic vein
    À§´«Á¤¸Æ
    [¿¾ ¿ë¾î] »ó¾ÈÁ¤¸Æ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neomycin
    ³×¿À¸¶À̽Å
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ophthalmic
    ´«ÀÇ
  • ophthalmic nerve
    ´«½Å°æ, ¾È½Å°æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BPN bacitracin, polymyxin B, neomycin sulfate; brachial plexus neuropathy
PBN paralytic brachial neuritis; peripheral benign neoplasm; polymyxin B sulfate, bacitracin, and neomyc...
PB British pharmacopeia [Pharmacopoeia Britannica]; paraffin bath; Paul-Bunnell [antibody]; periodic br...
PLET polymyxin, lysozyme, EDTA, and thallous acetate [in heart infusion agar]
PMB papillomacular bundle; para-hydroxymercuribenzoate; polychrome methylene blue; polymorphonuclear bas...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
OA Ophthalmic Artery
SOV superior ophthalmic vein
PB Polymyxin B
PMX-B Polymyxin B
PXB Polymyxin B
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • neomycin
    ³×¿À¸¶À̽Å
    ste
  • neomycin
    ³×¿À¸¶À̽Å
    ¹æ¼±±Õ
  • inferior ophthalmic vein
    ÇÏ¾È Á¤¸Æ
    ±ÙÁö ¹× ¸ð¾çü ºÐÁö¿¡ ÀÇÇØ Çü¼ºµÇ¸ç, ÈĹæÀ¸·Î ÁÖÇàÇÏ¿© »ó¾È Á¤¸Æ°ú ¸¸³ª°Å³ª ÇØ¸é Á¤¸Æµ¿À¸·Î Á÷Á¢ °³±¸ÇÑ´Ù.
  • ophthalmic acid
    ¿ÀÇÁÅ»¹Î»ê
    ¼ÒÀÇ ¼öÁ¤Ã¼ Áß¿¡ Á¸ÀçÇÏ´Â Æ®¶óÀÌ ÆéŸÀ̵å.
  • ophthalmic branch
    ¾È¿Í ºÐÁö, ¾È ºÐÁö
  • ophthalmic nerve
    ´« ½Å°æ, ¾È ½Å°æ
  • ophthalmic ointment
    ¾È ¿¬°í
  • ophthalmic solution
    ¾È°ú¿ë ¾×Á¦
  • ophthalmic vein
    ´« Á¤¸Æ, ¾È Á¤¸Æ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
neomycin <drug> Either of two aminoglycosides (B & C) produced by Streptomyces fradiae that have generalised antibiotic activity.
Neomycin A (Ineamine) contains 2 deoxy 1,3 diamino inositol combined with the aminoglycoside.
(18 Nov 1997)
neomycin sulfate The sulfate of an antibacterial antibiotic substance produced by the growth of Streptomyces fradiae, active against a variety of Gram-positive and Gram-negative bacteria.
(05 Mar 2000)
polymyxin <chemical> Basic polypeptide antibiotic group obtained from bacillus polymyxa. They affect the cell membrane by detergent action and may cause neuromuscular and kidney damage. at least eleven different members of the polymyxin group have been identified, each designated by a letter.
Pharmacological action: antibiotics, peptide.
(12 Dec 1998)
polymyxin acylase <enzyme> Deacylates polymyxin, colistin and octapeptin antibiotic
Registry number: EC 3.5.1.-
(26 Jun 1999)
polymyxin b <chemical> A mixture of polymyxins b1 and b2, obtained from bacillus polymyxa strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Polymyxin b is used for infections with gram-negative organisms, but may be neurotoxic and nephrotoxic.
Pharmacological action: antibiotics, peptide.
Chemical name: Polymyxin B
(12 Dec 1998)
polymyxin B sulfate An antibacterial effective in tularaemia, brucellosis, Pseudomonas infections, and urinary tract infections, but used systemically only for severe infections not responsive to less toxic agents; it is also used locally. Polymyxin B is a mixture of polymyxin B1 and polymyxin B2.
(05 Mar 2000)
prednisolone <chemical> A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
Pharmacological action: steroidal anti-inflammatory agents, antineoplastic agent, hormonal, glucocorticoids, synthetic.
Chemical name: Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-
(12 Dec 1998)
prednisolone butylacetate prednisolone tebutate
prednisolone sodium phosphate Prednisolone 21-(disodium phosphate);more soluble than prednisolone and the other prednisolone esters and useful when a rapid onset or a short duration of action is desired; suitable for intrasynovial, parenteral, and topical administration.
Prednisolone succinate, prednisolone compound suitable for intramuscular, intravenous, or rectal administration.
Prednisolone tebutate, same actions and uses as prednisolone but with longer duration of action and suitable for intrasynovial and soft tissue injection.
Synonym: prednisolone butylacetate.
(05 Mar 2000)
prednisolone, topical Prednisolone that is applied topically as an anti-inflammatory agent.
(12 Dec 1998)
meningeal branch of ophthalmic nerve <anatomy, nerve> See: tentorial nerve.
(05 Mar 2000)
superior ophthalmic vein <anatomy, vein> Begins anteriorly from the nasofrontal vein, passes along the upper part of the medial wall of the orbit, passes through the superior orbital fissure, to empty into the cavernous sinus.
Synonym: vena ophthalmica superior.
(05 Mar 2000)
inferior ophthalmic vein <anatomy, vein> Arises from the inferior palpebral and lacrimal veins and divides into two terminal branches, one of which runs to the pterygoid plexus while the other joins the superior ophthalmic vein or empties into the cavernous sinus.
Synonym: vena ophthalmica inferior.
(05 Mar 2000)
ophthalmic <anatomy> Pertaining to the eye.
(18 Nov 1997)
ophthalmic acid A tripeptide occurring in lens, similar to glutathione but differing in the replacement of cysteine by alpha-amino-n-butyric acid (i.e., in the replacement of -SH by -CH3); a potent inhibitor of glyoxalase.
Compare: norophthalmic acid.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neomycin
    ³×¿À¸¶À̽Å(¹æ»ç±Õ¿¡¼­ ¾ò´Â Ç×»ý¹°ÁúÀÇ ÀÏÁ¾)
  • ophthalmic
    ´«ÀÇ;¾È°úÀÇ;¾È¿°ÀÇ;¾È¾à
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á